Opendata, web and dolomites

Athero MPh proliferation

Macrophage proliferation and ontogeny in murine models of atherosclerosis

Total Cost €


EC-Contrib. €






 Athero MPh proliferation project word cloud

Explore the words cloud of the Athero MPh proliferation project. It provides you a very rough idea of what is the project "Athero MPh proliferation" about.

formed    atherosclerosis    versa    compare    quantify    notion    transcriptomics    death    couple    versus    differentiated    circulating    therapeutic    eminent    local    proliferation    mapping    animal    myeloid    introduce    transfers    conclusively    localization    subverted    slowly    strategy    vascular    function    lipidic    question    models    interventions    inflammatory    proliferated    underlies    contribution    clonal    stromal    intraplaque    progressing    unclear    quantifying    experimental    trans    adoptive    central    atherosclerotic    lack    recruitment    disease    macrophage    capacity    deploy    invaded    expansion    fate    cells    western    monocytes    accumulation    mouse    makeup    model    wt    resident    marrow    plaque    course    apart    vice    lipidomics    view    phenotype    intervention    monocyte    regions    mainly    pathogenesis    causes    bone    muscle    regression    transcriptional    first    proliferative    society    cell    link    assessing    launching    progression    smooth    recruited    mechanisms    ubow    reveal    macrophages    mice    originate    relative    lysmcre   

Project "Athero MPh proliferation" data sheet

The following table provides information about the project.


Organization address
address: Minderbroedersberg 4-6
postcode: 6200 MD

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website
 Total cost 177˙598 €
 EC max contribution 177˙598 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-02-01   to  2018-01-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Atherosclerosis is a slowly progressing inflammatory disease that underlies some of the most common causes of death in western society. The central role of macrophages throughout its pathogenesis makes this cell an eminent target for therapeutic intervention. Recent studies have subverted the classical view that atherosclerotic plaque macrophages mainly originate from recruited circulating monocytes, launching the new notion that macrophages could also be derived from clonal expansion of resident macrophages or even trans-differentiated vascular smooth muscle cells. The relative importance of these mechanisms to the pathogenesis remains however unclear, due to a lack of adequate animal models that allow assessing this question. In this project, I introduce a recently developed fate mapping model, the LysMCre-Ubow/ mouse, into the atherosclerosis field to conclusively identify regions within the plaque that were formed through local proliferation rather than monocyte recruitment. Apart from quantifying its relative contribution to plaque growth during disease progression and regression, I will furthermore characterize the localization, transcriptional activity and the lipidic makeup of these proliferated cells versus invaded monocytes. In a second part of this project, I will deploy adoptive bone marrow transfers from WT to Ubow mice and vice versa as a model to quantify intraplaque myeloid versus stromal-cell derived macrophages. I will compare proliferative capacity, phenotype, transcriptomics and lipidomics of these two subsets and link this information to their functionality. With this strategy I will be the first to reveal the impact of the three macrophage accumulation mechanisms throughout the disease course, to couple this to their function and to exploit this knowledge for targeted experimental therapeutic interventions.


year authors and title journal last update
List of publications.
2017 Emiel P.C. van der Vorst, Kosta Theodorou, Yongzheng Wu, Marten A. Hoeksema, Pieter Goossens, Christina A. Bursill, Taghi Aliyev, Leonie F.A. Huitema, Sander W. Tas, Ine M.J. Wolfs, Marijke J.E. Kuijpers, Marion J. Gijbels, Casper G. Schalkwijk, Debby P.Y. Koonen, Shahla Abdollahi-Roodsaz, Kimberly McDaniels, Chih-Chieh Wang, Michael Leitges, Toby Lawrence, Jogchum Plat, Miranda Van Eck, Kerry-Anne Rye, Lhousseine Touqui, Menno P.J. de Winther, Erik A.L. Biessen, Marjo M.P.C. Donners
High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling
published pages: 197-207, ISSN: 1550-4131, DOI: 10.1016/j.cmet.2016.10.013
Cell Metabolism 25/1 2019-06-18
2017 Jan Nagenborg, Pieter Goossens, Erik A.L. Biessen, Marjo M.P.C. Donners
Heterogeneity of atherosclerotic plaque macrophage origin, phenotype and functions: Implications for treatment
published pages: 14-24, ISSN: 0014-2999, DOI: 10.1016/j.ejphar.2017.10.005
European Journal of Pharmacology 816 2019-06-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ATHERO MPH PROLIFERATION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ATHERO MPH PROLIFERATION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)


Identification and characterisation of new class of PI3K modulators in oncology

Read More  

FOCUSIS (2020)

Focal volume Control Using Structured Illumination Sources

Read More  

NeoPur (2019)

New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling.

Read More